MICU1
protein-codingmitochondrial calcium uptake 1, the group of EF-hand domain containing
Gene summary
This gene encodes an essential regulator of mitochondrial Ca2+ uptake under basal conditions. The encoded protein interacts with the mitochondrial calcium uniporter, a mitochondrial inner membrane Ca2+ channel, and is essential in preventing mitochondrial Ca2+ overload, which can cause excessive production of reactive oxygen species and cell stress. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Mar 2013]
- CBARA1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~258.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014300
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014300
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0014300
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *MICU1* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of November 20, 2023. *MICU1* encodes mitochondrial calcium uptake protein 1. This is a key regulator of the mitochondrial calcium uniporter (MCU), a multi-subunit calcium channel of the mitochondrial inner membrane. MICU1 senses calcium levels via its EF-hand domains. *MICU1* was first reported in relation to autosomal recessive primary mitochondrial disease in 2014 (PMID: 24336167). While various names have been given to the constellation of features seen in those with *MICU1*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the MICU1 phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting the relationship between *MICU1* and autosomal recessive primary mitochondrial disease includes case-level data and experimental data. This curation included two nonsense variants and two splicing / frameshift variants resulting in truncation observed in four probands in three publications (PMIDs: 24336167, 29721912, 33969448). All cases included in this curation were homozygous for the variant, and parents were confirmed carriers. There are additional cases reported in the medical literature (PMIDs: 33428302, 32395406, 36425804, 27123478), including individuals with exonic level deletions, however these were not included in this curation as the maximum genetic evidence score was reached. Age of onset is typically in early childhood but can also be seen up to adulthood. Clinical features in affected individuals include myopathy, developmental delay, ataxia, extrapyramidal signs, chorea, tremor, dystonia, microcephaly, neuropathy, optic atrophy, and ophthalmoplegia. The mechanism of disease is loss of function. This gene-disease association is also supported by a expression in brain and muscle, and several mouse models showing the impact of *MICU1* knockout on mitochondrial calcium uptake (PMIDs: 24336167, 27477272, 35302860). In summary, there is definitive evidence to support the relationship between *MICU1* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on November 20, 2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0014300
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014300
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014300
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MICU1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001195518.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 69 | 1 | 72 | ||
| missense | 1 | 104 | 2 | 1 | 108 | |
| nonsense | 10 | 3 | 13 | |||
| start loss | 1 | 1 | ||||
| frameshift | 10 | 5 | 15 | |||
| splice donor/acceptor (+/-2bp) | 2 | 11 | 1 | 14 | ||
| Total | 22 | 21 | 107 | 71 | 2 | 223 |
Highest pathogenic variant AF is 0.00014505025
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001182447.1 | 11 | MANE Select | |
| Ensembl | ENSP00000354415.5 | 11 | MANE Select | |
| RefSeq | NP_001182448.1 | 7 | Standard | |
| RefSeq | NP_001350442.1 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transport of small molecules
- Mitochondrial calcium ion transport
- Processing of SMDT1
Biological Process
- mitochondrial calcium ion transmembrane transport
- defense response
- calcium import into the mitochondrion
- protein homooligomerization
- mitochondrial calcium ion homeostasis
Molecular Function
- calcium ion binding
- protein binding
- identical protein binding
- protein heterodimerization activity
Cellular Component
- mitochondrion
- mitochondrial inner membrane
- mitochondrial intermembrane space
- integral component of mitochondrial membrane
- calcium channel complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000361114
- Coding exons
- 11
- Length
- 258802
- Individuals with no LoFs
- 124581
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 63
- Defined
- 124644
- p
- 0.000253
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.65 | 174 | 247 | 0.704 | 0.0000130 | 3145 |
| Missense (PolyPhen) | 31 | 67.052 | 0.46233 | 844 | ||
| Synonymous | 0.839 | 73 | 82.7 | 0.883 | 0.00000402 | 873 |
| Loss of Function | 0.465 | 21 | 23.4 | 0.896 | 0.00000145 | 280 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00019 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0.000048 | 0.000046 | rare |
| European (Non-Finnish) | 0.00029 | 0.00027 | rare |
| South Asian | 0.00053 | 0.00052 | rare |
| Other | 0.00019 | 0.00017 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Key regulator of mitochondrial calcium uniporter (MCU) that senses calcium level via its EF-hand domains (PubMed:20693986, PubMed:23101630, PubMed:23747253, PubMed:24313810, PubMed:24332854, PubMed:24503055, PubMed:24560927, PubMed:26341627, PubMed:26903221, PubMed:27099988). MICU1 and MICU2 form a disulfide-linked heterodimer that stimulates and inhibits MCU activity, depending on the concentration of calcium. MICU1 acts both as an activator or inhibitor of mitochondrial calcium uptake (PubMed:26903221). Acts as a gatekeeper of MCU at low concentration of calcium, preventing channel opening (PubMed:26903221). Enhances MCU opening at high calcium concentration, allowing a rapid response of mitochondria to calcium signals generated in the cytoplasm (PubMed:24560927, PubMed:26903221). Regulates glucose-dependent insulin secretion in pancreatic beta-cells by regulating mitochondrial calcium uptake (PubMed:22904319). Induces T-helper 1-mediated autoreactivity, which is accompanied by the release of IFNG (PubMed:16002733). {ECO:0000269|PubMed:16002733, ECO:0000269|PubMed:20693986, ECO:0000269|PubMed:22904319, ECO:0000269|PubMed:23101630, ECO:0000269|PubMed:23747253, ECO:0000269|PubMed:24313810, ECO:0000269|PubMed:24332854, ECO:0000269|PubMed:24503055, ECO:0000269|PubMed:24560927, ECO:0000269|PubMed:26341627, ECO:0000269|PubMed:26903221, ECO:0000269|PubMed:27099988}.;
- Disease
- DISEASE: Myopathy with extrapyramidal signs (MPXPS) [MIM:615673]: An autosomal recessive disorder characterized by early-onset proximal muscle weakness with a static course and moderately to grossly elevated serum creatine kinase levels accompanied by learning difficulties. Most patients develop subtle extrapyramidal motor signs that progress to a debilitating disorder of involuntary movement with variable features, including chorea, tremor, dystonic posturing and orofacial dyskinesia. Additional variable features include ataxia, microcephaly, ophthalmoplegia, ptosis, optic atrophy and axonal peripheral neuropathy. {ECO:0000269|PubMed:24336167}. Note=The disease is caused by mutations affecting the gene represented in this entry. The complex phenotype is due to alterations in mitochondrial calcium signaling characterized by increased mitochondrial Ca(2+) load (PubMed:24336167). {ECO:0000269|PubMed:24336167}.; DISEASE: Note=An homozygous partial MICU1 deletion is responsible for a disorder manifesting in childhood with fatigue, lethargy and muscle weakness. The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:27123478}.;
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- RVIS EVS
- -0.45
- RVIS percentile EVS
- 24.19
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |